Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Solitary Kidney”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00830674
What this trial is testing

KRN23 in X-linked Hypophosphatemia

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd. 42
Testing effectiveness (Phase 2)Study completedNCT02706886
What this trial is testing

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Pharmaceuticals 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT06729853
What this trial is testing

PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
GoutHyperuricemia
Shanton Pharma Pte. Ltd. 32
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Not applicableActive Not RecruitingNCT05696444
What this trial is testing

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Who this might be right for
Bladder CancerProstate CancerKidney Cancer+6 more
Medtronic - MITG 144
Testing effectiveness (Phase 2)Looking for participantsNCT06354231
What this trial is testing

DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC

Who this might be right for
Renal InsufficiencyUpper Urinary Tract Urothelial CarcinomaSolitary Kidney
Fudan University 20
Testing effectiveness (Phase 2)Study completedNCT01336972
What this trial is testing

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 29
Early research (Phase 1)Not Yet RecruitingNCT07181265
What this trial is testing

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jemincare 48
Early research (Phase 1)Study completedNCT05429073
What this trial is testing

RGLS8429 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Regulus Therapeutics Inc. 32
Early research (Phase 1)Looking for participantsNCT07788014
What this trial is testing

Single and Multiple Ascending Doses of GV-100

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Gilva Therapeutics Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00679991
What this trial is testing

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease
Proteon Therapeutics 66
Not applicableStudy completedNCT03513718
What this trial is testing

Acute Kidney Injury After Cardiac Surgery on CPB

Who this might be right for
Acute Kidney InjuryCongenital Heart DiseaseSurgery+2 more
Centre Hospitalier Universitaire Vaudois 250
Not applicableStudy completedNCT04869462
What this trial is testing

DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)

Who this might be right for
Prostate CancerKidney CancerCongenital Abnormality of Kidney+5 more
Aesculap AG 67
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731192
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome

Who this might be right for
Alport Syndrome
Guangzhou Women and Children's Medical Center 40
Post-approval studies (Phase 4)Study completedNCT04842032
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 28
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Next Page